Label: CAREONE MAXIMUM REDNESS RELIEF EYE DROPS- glycerin, naphazoline hci solution/ drops

  • NDC Code(s): 72476-012-01
  • Packager: Retail Business Services, LLC
  • Category: HUMAN OTC DRUG LABEL

Drug Label Information

Updated December 23, 2023

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

View All Sections
  • Active ingredients

    Glycerin 0.5%

    Naphazoline HCI 0.03%

  • Purposes

    Lubricant

    Redness reliever

  • Uses

    • for the relief of redness of the eye due to minor eye irriatations
    • for the temporary relief of burning and irritation due to dryness of the eye
    • for use as a protectant against further irritation or dryness of the eye
  • Warnings

    For external use only

    Do not use

    if solution changes color or becomes cloudy

    Ask a doctor before use if you have

    narrow angle glaucoma

    When using this product

    • to avoid contamination, do not touch tip of container to any surface
    • replace cap after using
    • overuse may produce increased redness of the eye
    • pupils may become enlarged temporarily

    Stop use and ask a doctor if

    • you experience eye pain
    • you experience changes in vision
    • you experience continued redness or irritation of the eye
    • the condition worsens or persists for more than 72 hours

    Keep out of reach of children.

    If swallowed, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

  • Directions

    ​instill 1 or 2 drops in the affected eye(s) up to 4 times daily.

  • Other information

    • store at room temperature
    • remove contact lenses before using
  • Inactive ingredients

    benzalkonium chloride, boric acid, edetate disodium, purified water, sodium borate

  • Questions or comments?

    Call 1-888-527-4276

  • CareOne Maximum Redness Relief Eye Drops 15mL

    CareOne Maximum Redness Relief Eye Drops 15mL

  • INGREDIENTS AND APPEARANCE
    CAREONE MAXIMUM REDNESS RELIEF EYE DROPS 
    glycerin, naphazoline hci solution/ drops
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:72476-012
    Route of AdministrationOPHTHALMIC
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    GLYCERIN (UNII: PDC6A3C0OX) (GLYCERIN - UNII:PDC6A3C0OX) GLYCERIN0.5 g  in 100 mL
    NAPHAZOLINE HYDROCHLORIDE (UNII: MZ1131787D) (NAPHAZOLINE - UNII:H231GF11BV) NAPHAZOLINE HYDROCHLORIDE0.03 g  in 100 mL
    Inactive Ingredients
    Ingredient NameStrength
    BENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7)  
    BORIC ACID (UNII: R57ZHV85D4)  
    SODIUM BORATE (UNII: 91MBZ8H3QO)  
    EDETATE DISODIUM (UNII: 7FLD91C86K)  
    WATER (UNII: 059QF0KO0R)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:72476-012-011 in 1 BOX01/12/2020
    115 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM01801/12/2020
    Labeler - Retail Business Services, LLC (967989935)
    Registrant - KC Pharmaceuticals, Inc. (174450460)
    Establishment
    NameAddressID/FEIBusiness Operations
    KC Pharmaceuticals, Inc.174450460manufacture(72476-012) , pack(72476-012) , label(72476-012)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials

More Info on this Drug

Get Label RSS Feed, View NDC Code(s)NEW!